Sales beat across the board Q1 22 sales came in at EUR144m, up 19.6%, of which 16.4% was LFL. We were expecting sales of EUR134m and organic growth at 10.5%. The upside to forecasts was driven by both nuclear and non-nuclear activities. Nuclear sales were up 15.7% LFL, accelerating from +9.5% in Q4 22 thanks to robust growth from the maintenance of the installed base in France (lifetime extension, decommissioning) and strong growth from new build in the UK. Non-nuclear sales gained 32.1%, o.w. 1 ....